MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-02-0013095
Obsurge Biotech Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹72.73 Cr
▲ 8% YoY
Net profit · FY 2025
₹6.25 Cr
Net margin 8.6%
EBITDA · FY 2025
₹9.22 Cr
EBITDA margin 12.7%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹28.15 Lakh
Issued & subscribed
Open charges
₹25.88 Lakh
Satisfied ₹5.02 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
606
Provident fund records
About Obsurge Biotech Limited
Data last updated:
Obsurge Biotech Limited is a public limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 January 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2002PLC113701. Its GSTIN is 07AAACO5037A2ZY (Delhi). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹28.15 Lakh. It is led by directors including Avijit Chauhan (Managing Director) and Latish Malhotra (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 101 – 102 Aditya Tower District Centre Laxmi Nagar, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹72.73 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹6.25 Cr (net margin 8.6%) and EBITDA of ₹9.22 Cr (EBITDA margin 12.7%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 10% over five years.
The company has about 606 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Obsurge Biotech. As per MCA filings, the company has open charges of ₹25.88 Lakh and satisfied charges of ₹5.02 Cr on record. Court records list 16 cases involving the company, including 14 filed by the company and 2 filed against it; 1 case is pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in March 2016. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Venkatasai Agencies Hyd Private Limited with revenue of ₹73.45 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 49 overdue payments to 30 micro and small suppliers.
Obsurge Biotech Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0013095). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website obsurge.com.
Company Details of Obsurge Biotech Limited
CIN U24232DL2002PLC113701
Registration Number 113701
Incorporation Date 04 January 2002
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-02-0013095
Key People
Avijit Chauhan Managing Director Latish Malhotra Whole-Time Director Amin Ul Aziz Director Recognitions & Rankings of Obsurge Biotech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address101 – 102 Aditya Tower District Centre Laxmi Nagar, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Obsurge Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Obsurge Biotech Limited
Obsurge Biotech operates one associated brand: Obsurge Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures healthcare products focused on cardiology, dentistry, and other therapeutic areas. | obsurge.com |
Business Activity of Obsurge Biotech Limited
The main business activity of Obsurge Biotech is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Obsurge Biotech Limited FY 2024 filings available
Obsurge Biotech Limited reported revenue of ₹72.73 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹72.73 Cr ▲ 8%
Net profit · FY 2025
₹6.25 Cr margin 8.6%
EBITDA · FY 2025
₹9.22 Cr margin 12.7%
Compounded Annual Growth Rate (CAGR) of Obsurge Biotech Limited
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 13%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 10%
5 years · compounded
▼ 7%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 8% growth in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Obsurge Biotech Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.22 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.25 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Obsurge Biotech Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Obsurge Biotech are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Obsurge Biotech Limited
Obsurge Biotech has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avijit Chauhan Also directs: Smartcity Distributors LLP | Managing Director | 07 Jan 2008 | 18 Years 9 Months | Current |
| Amin Ul Aziz Also directs: Bhujadhari Vincom Private Limited, F & S Trading Private Limited, Rosebud Tradelink Private Limited and 2 more | Director | 03 Apr 2015 | 11 Years 6 Months | Current |
| Jaswant Singh Chauhan | Director | 04 Jan 2002 | 24 Years 9 Months | Current |
| Latish Malhotra Also directs: Jagdish Medicare Private Limited | Whole-Time Director | 04 Jan 2002 | 24 Years 9 Months | Current |
Peer Comparison of Obsurge Biotech Limited
Obsurge Biotech Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Venkatasai Agencies Hyd Private Limited | ₹73.45 Cr (FY 2023) | •••• | •••• | -5.0% | •••• | Hyderabad, Telangana, India |
| Nidhi Associates Private Limited | ₹73.36 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | New Delhi, Delhi, India |
| Aastrid International Private Limited | ₹72.84 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Mumbai, Maharashtra, India |
| NV Remedies Private Limited | ₹72.84 Cr (FY 2025) | •••• | •••• | 78.0% | •••• | Navi Mumbai, Maharashtra, India |
| Anila Medical Private Limited | ₹72.79 Cr (FY 2025) | •••• | •••• | 40.0% | •••• | Indore, Madhya Pradesh, India |
| Obsurge Biotech Limited this company | ₹72.73 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Delhi, India |
| Sweta Distributors Private Limited | ₹72.34 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Thane, Maharashtra, India |
| Makers Pharma Private Limited | ₹72.25 Cr (FY 2022) | •••• | •••• | 72.0% | •••• | Chennai, Tamil Nadu, India |
| Arinna Lifesciences Limited | ₹72.24 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Ahmedabad, Gujarat, India |
| Palod Distributors Private Limited | ₹71.74 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Jalgaon, Maharashtra, India |
| G R Health Aids Private Limited | ₹71.4 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Obsurge Biotech by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Obsurge Biotech Limited
Obsurge Biotech Limited is audited by VBR & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VBR & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Obsurge Biotech Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Obsurge Biotech Limited
Open charges
₹25.88 Lakh
Satisfied charges
₹5.02 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2022 | Hdfc Bank Limited | ₹25.88 Lakh | Open |
| 30 May 2018 | Hdfc Bank Limited | ₹2 Cr | Satisfied |
| 28 Feb 2013 | Citibank N.A | ₹1.5 Cr | Satisfied |
| 02 Sep 2002 | Union Bank of India | ₹1.52 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Obsurge Biotech Limited
Obsurge Biotech Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in March 2016.
Total deals
5
Secondary share transfers
4
Funding round
1
Disclosed funding
₹10 Lakh
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Jaswant Singh Chauhan Huf Seller: an individual |
| Jan 2010 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Jan 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2007 | Funding round | ₹10 Lakh | Investors: an individual |
| Mar 2006 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
Premium access
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Obsurge Biotech Limited
Obsurge Biotech Limited has 16 court cases on record: 14 filed by Obsurge Biotech, 2 filed against it. 1 case is pending and 15 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Total cases
16
Filed by the company
14
Filed against the company
2
Pending
1
Disposed
15
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 0 | 0 |
| District courts | 3 | 2 | 1 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CS(OS)) | Filed by the company against Goodman Gilman's Life Sciences Private Limited | Disposed |
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Anr | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Union of India | Disposed |
Premium access
Full case history
All 16 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Obsurge Biotech Limited
Obsurge Biotech Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 49 overdue payments to 30 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 30)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Needs | •••• | •••• | •••• |
| Essen Medicare LLP | •••• | •••• | •••• |
| Medicine Agencies | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Global Pharmaceuticals | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Obsurge Biotech Limited
Obsurge Biotech Limited has a workforce of 606 employees as of Sep 22, 2025.
Employee count
606
Active EPFO establishments
1
Employee growth
-2.42%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Obsurge Biotech Limited
Obsurge Biotech Limited has 8 board changes on record since 2002: 4 appointments and 4 cessations. The latest: Avijit Chauhan ceased to be Whole-Time Director on 01 Apr 2021.
AGM
Obsurge Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Obsurge Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 30 May 2018 via Charge ID 100202488 with Hdfc Bank Limited was fully satisfied on 02 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.88 Lakh with Charge ID 100565326 was registered on 29 Mar 2022.
Ceased
Avijit Chauhan ceased to be Whole-Time Director.
Ceased
Jaswant Singh Chauhan ceased to be Managing Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 200.00 Lakh with Charge ID 100202488 was registered on 30 May 2018.
Ceased
Amin Ul Aziz ceased to be Additional Director.
Appointed
Amin Ul Aziz was appointed as Director.
Charges
A charge registered on 28 Feb 2013 via Charge ID 10413658 with Citibank N.A was fully satisfied on 15 Mar 2014.
Charges
A charge registered on 02 Sep 2002 via Charge ID 80018193 with Union Bank Of India was fully satisfied on 01 May 2013.
Charges
A charge with Citibank N.A amounted to Rs. 150.00 Lakh with Charge ID 10413658 was registered on 28 Feb 2013.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Obsurge Biotech Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Obsurge Biotech Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Obsurge Biotech Limited
Obsurge Biotech has 5 GST registrations: 4 active and 1 cancelled or inactive.
Total GSTINs
5
Active
4
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACO5037A2ZY | Delhi | Active | 12 Jul 2017 |
| 09AAACO5037A1ZV | Uttar Pradesh | Active | 01 Jul 2017 |
| 06AAACO5037A1Z1 | Haryana | Active | 14 Jul 2021 |
| 18AAACO5037A1ZW | Assam | Active | 09 Mar 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Obsurge Biotech Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Obsurge Biotech Limited
Obsurge Biotech is an active public limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 January 2002 (24+ years old) and is registered under CIN U24232DL2002PLC113701.
Obsurge Biotech reported revenue of ₹72.73 Cr for FY 2025 (up 8% YoY).
Obsurge Biotech has 4 current directors:
- Avijit Chauhan - Managing Director
- Latish Malhotra - Whole-Time Director
- Amin Ul Aziz - Director
- Jaswant Singh Chauhan - Director
Obsurge Biotech reported a net profit of ₹6.25 Cr (net margin 8.6%) and EBITDA of ₹9.22 Cr (EBITDA margin 12.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Obsurge Biotech is 13% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Obsurge Biotech is 07AAACO5037A2ZY, registered in Delhi. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 09AAACO5037A1ZV (Uttar Pradesh), 06AAACO5037A1Z1 (Haryana), 18AAACO5037A1ZW (Assam).
The CIN (Corporate Identification Number) of Obsurge Biotech is U24232DL2002PLC113701. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Obsurge Biotech has 16 court cases on record: 14 filed by the company and 2 filed against it. 1 is pending. Most are in the high courts.
Obsurge Biotech was incorporated on 04 January 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.
Obsurge Biotech has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in March 2016.
The peers of Obsurge Biotech by revenue are Venkatasai Agencies Hyd Private Limited, Nidhi Associates Private Limited, Aastrid International Private Limited, NV Remedies Private Limited, Anila Medical Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Avijit Chauhan ceased to be Whole-Time Director on 01 Apr 2021. Jaswant Singh Chauhan ceased to be Managing Director on 31 Mar 2021. Amin Ul Aziz ceased to be Additional Director on 30 Sep 2015. Obsurge Biotech has 8 board changes on record in total.